We are thrilled to announce that Grant Round 1, 2022 Captain Courageous Fellowship has been awarded to Dr Astrid Glaser at St Vincent’s Institute of Medical Research.
This research aims to provide an alternative treatment to Fanconi Anaemia, a serious genetic disorder that leads to bone marrow failure. Currently the only treatment for Fanconi Anaemia is a bone marrow transplant from a donor, with high risk of complications.
Dr Astrid Glaser is a gene therapy expert. Her goal is to develop ways to ‘edit’ errors in a person’s DNA to ultimately cure inherited diseases. Astrid’s current focus is gene editing techniques with the goal of repairing the underlying changes in a person’s DNA that cause inherited Bone Marrow Failure Syndromes.
Inherited conditions are particularly difficult to treat because they are caused by changes (mutations) in the person’s individual genetic blueprint – their DNA. Gene editing technology offers the potential for scientists to locate and fix the mutations that drive disease in this DNA blueprint – a goal which would ultimately cure many genetic disorders.
Dr Glaser’s Fellowship will enable the development of new gene editing tools to repair the DNA mutations that cause Fanconi Anaemia, the most common inherited Bone Marrow Failure Syndrome.
“Gene therapy holds the potential to rescue bone marrow failure without the dangerous complications associated with a transplant from a donor,” Dr Glaser explains. “My hope for this research is that we will be able to expand our work to other inherited Bone Marrow Failure Syndromes, laying the foundation for a clinical trial to improve the lives of Australian patients and their families.”
This exciting research is possible thanks to our partners at Captain Courageous. “We are very excited to award Dr Glaser’s research with the inaugural Captain Courageous fellowship. This research is a very important key to understanding Bone Marrow Failure Syndromes. We can’t wait to hear the outcome.”
Dr Glaser is a postdoctoral researcher at St Vincent’s Institute of Medical Research in Melbourne. She completed a PhD at the Murdoch Children’s Research Institute (MCRI) focusing on gene therapy for the inherited blood disorder beta-thalassaemia, and a Diploma in Immunology at University of Vienna focused on immunotherapies for malignant melanoma.
For the 6th year in a row, Australians can make a big difference to people with Bone Marrow Failure Syndromes just by popping a bunch of Flavorite tomatoes or capsicums in ...Read more
This is the most exciting research news for patients with inherited bone marrow failure....Read more
Maddie Riewoldt's Vision, the Snowdome Foundation and the Gunn Family are thrilled to...Read more
The Board of Maddie’s Vision is delighted to introduce our new CEO, Amy Coote. Amy will be officially joining us on 15 November, and we’re excited to welcome her to the ...Read more